Objective To investigate the association between Chinese Adult Body Shape Index (CABSI) and reduced skeletal muscle index (SMI) in male patients with type 2 diabetes mellitus (T2DM). Methods A total of 168 male inpatients with T2DM admitted to the Department of Endocrinology, Chengde Central Hospital, between December 2024 and October 2025 were enrolled. According to the Asian Working Group for Sarcopenia criteria (SMI<7.0 kg/m²), participants were classified into a reduced SMI group (n=65) and a normal SMI group (n=103). General data, laboratory parameters, and anthropometric measurements were collected, and CABSI was calculated. Spearman rank correlation analysis was used to evaluate the correlation between CABSI and SMI. With reduced SMI as the dependent variable and CABSI quartiles (Q1 as the reference) modeled as three dummy variables, candidate covariates were screened by univariate analysis and assessed for collinearity before entry into a multivariate logistic regression model to identify factors associated with reduced SMI. Results The detection rate of SMI was 38.69% (65/168). Compared with the normal SMI group, the reduced SMI group had significantly lower body weight, waist circumference, hip circumference, body mass index, waist-to-height ratio, and serum levels of albumin, triglycerides, uric acid, and creatinine, and significantly higher CABSI and serum HDL-C levels (all P<0.05). Spearman rank correlation analysis revealed a weak negative correlation between CABSI and SMI (rₛ=−0.253, P<0.001). Multivariate logistic regression analysis showed that, after adjustment for covariates, patients in the highest CABSI quartile (Q4) had a higher risk of reduced SMI than those in the lowest quartile (Q1) (OR=3.196, 95% CI: 1.125-9.078, P=0.029). Lower serum albumin and creatinine levels were also independently associated with an increased risk of reduced SMI (albumin: OR=0.849, 95% CI: 0.750-0.961, P=0.010; creatinine: OR=0.958, 95% CI: 0.936-0.981, P<0.001). Conclusion Higher CABSI is independently associated with an increased risk of reduced SMI in male patients with T2DM, particularly in the highest quartile. Given its simplicity and accessibility, CABSI may serve as a reference indicator for screening for reduced SMI risk in male patients with T2DM.